Coya Therapeutics Inc

Research Coya Therapeutics Inc (COYA) on Bullrun: market cap USD 142.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCOYA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 142.39M
• Financial periodFY2025
• RevenueUSD 7.95M
• Revenue growth123.6%
• Net income-USD 21.23M

Valuation Snapshot

latest market cap is USD 142.39M.

About Coya Therapeutics Inc

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.

Frequently asked questions

What is Coya Therapeutics Inc's market cap?

Coya Therapeutics Inc's market capitalization is USD 142.39M.

What does Coya Therapeutics Inc do?

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs).